{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:23:57Z","timestamp":1763641437887},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,3,30]],"date-time":"2011-03-30T00:00:00Z","timestamp":1301443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00417-011-1651-7","type":"journal-article","created":{"date-parts":[[2011,3,29]],"date-time":"2011-03-29T10:44:54Z","timestamp":1301395494000},"page":"1159-1166","source":"Crossref","is-referenced-by-count":16,"title":["Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up"],"prefix":"10.1007","volume":"249","author":[{"given":"J. Fernando","family":"Arevalo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan V.","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,30]]},"reference":[{"key":"1651_CR1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00006982-200506000-00005","volume":"25","author":"D Bujarborua","year":"2005","unstructured":"Bujarborua D, Chatterjee S, Choudhury A, Bori G, Sarma AK (2005) Fluorescein angiographic features of asymptomatic eyes in central serous chorioretinopathy. Retina 25:422\u2013429","journal-title":"Retina"},{"key":"1651_CR2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","volume":"86","author":"M Wang","year":"2008","unstructured":"Wang M, Munch IC, Hasler PW, Pr\u00fcnte C, Larsen M (2008) Central serous chorioretinopathy. Review article. Acta Ophthalmol 86:126\u2013145","journal-title":"Acta Ophthalmol"},{"key":"1651_CR3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006982-198700720-00009","volume":"7","author":"LA Yannuzzi","year":"1987","unstructured":"Yannuzzi LA (1987) Type A behavior and central serous chorioretinopathy. Retina 7:111\u2013131","journal-title":"Retina"},{"key":"1651_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006982-200202000-00004","volume":"22","author":"RH Loo","year":"2002","unstructured":"Loo RH, Scott IU, Flynn HW Jr, Gass JDM, Murray TG, Lewis ML, Rosenfeld PJ, Smiddy WE (2002) Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina 22:19\u201324","journal-title":"Retina"},{"key":"1651_CR5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ajo.2004.01.043","volume":"137","author":"M Taban","year":"2004","unstructured":"Taban M, Boyer DS, Thomas EL (2004) Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 137:1073\u20131080","journal-title":"Am J Ophthalmol"},{"key":"1651_CR6","first-page":"52","volume-title":"Stereoscopic atlas of macular diseases: diagnosis and treatment","author":"JDM Gass","year":"1997","unstructured":"Gass JDM (1997) Stereoscopic atlas of macular diseases: diagnosis and treatment, 4th edn. Mosby, St. Louis, pp 52\u201370","edition":"4"},{"key":"1651_CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ajo.2004.08.037","volume":"139","author":"F Cardillo","year":"2005","unstructured":"Cardillo F, Rigault R, Ravera G, Eandi CM, Ventre L, Abdollahi A, Manea M (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 139:87\u201399","journal-title":"Am J Ophthalmol"},{"key":"1651_CR8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archopht.122.1.37","volume":"122","author":"E Ergun","year":"2004","unstructured":"Ergun E, Tittl M, Stur M (2004) Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy. Arch Ophthalmol 122:37\u201341","journal-title":"Arch Ophthalmol"},{"key":"1651_CR9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/IAE.0b013e318156777f","volume":"28","author":"W-M Chan","year":"2008","unstructured":"Chan W-M, Lai TYY, Lai RYK, Tang EWH, Liu DTL, Lam DSC (2008) Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy. Retina 28:85\u201393","journal-title":"Retina"},{"key":"1651_CR10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00006982-200304000-00016","volume":"23","author":"PM Battaglia","year":"2003","unstructured":"Battaglia PM, Da Pozzo S, Ravalico G (2003) Photodynamic therapy in chronic central serous chorioretinopathy. Retina 23:235\u2013237","journal-title":"Retina"},{"key":"1651_CR11","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.4.524","volume":"117","author":"NM Bressler","year":"1999","unstructured":"Bressler NM (1999) Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trial-TAP report no. 1. Arch Ophthalmol 117:1329\u20131345","journal-title":"Arch Ophthalmol"},{"key":"1651_CR12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00417-002-0517-4","volume":"240","author":"U Schlotzer-Schrehardt","year":"2002","unstructured":"Schlotzer-Schrehardt U, Viestenz A, Naumann GO et al (2002) Dose-related structural effects of photodynamic therapy in human eyes. Arch Ophthalmol 240:748\u2013757","journal-title":"Arch Ophthalmol"},{"key":"1651_CR13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ajo.2007.02.039","volume":"143","author":"W-M Chan","year":"2007","unstructured":"Chan W-M, Lai TYY, Liu DTL, Lam DSC (2007) Intravitreal bevacizumab (Avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 143:977\u2013983","journal-title":"Am J Ophthalmol"},{"key":"1651_CR14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10384-008-0613-z","volume":"53","author":"PY Lee","year":"2009","unstructured":"Lee PY, Kim KS, Lee WK (2009) Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy. Jpn J Ophthalmol 53:52\u201356","journal-title":"Jpn J Ophthalmol"},{"key":"1651_CR15","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/bjo.87.12.1453","volume":"87","author":"W-M Chan","year":"2003","unstructured":"Chan W-M, Lam DSC, Lai TYY, Tam BSM, LIU DTL, Chan CKM (2003) Choroidal vascular remodeling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87:1453\u20131458","journal-title":"Br J Ophthalmol"},{"key":"1651_CR16","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/00006982-200312000-00002","volume":"23","author":"F Cardillo","year":"2003","unstructured":"Cardillo F, Eandi CM, Ventre L, De la Longrais R, Grignolo FM (2003) Photodynamic therapy for central serous chorioretinopathy. Retina 23:752\u2013763","journal-title":"Retina"},{"key":"1651_CR17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00006982-200306000-00002","volume":"23","author":"LA Yannuzzi","year":"2003","unstructured":"Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa DLL, Huang SJ, Klancnik JM Jr, Aizman A (2003) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy. A pilot study. Retina 23:288\u2013298","journal-title":"Retina"},{"key":"1651_CR18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00006982-200304000-00016","volume":"23","author":"MB Parodi","year":"2003","unstructured":"Parodi MB, Pozzo SDA, Ravalico G (2003) Photodynamic therapy in chronic central serous chorioretinopathy. Retina 23:235\u2013237","journal-title":"Retina"},{"key":"1651_CR19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0039-6257(00)00158-2","volume":"45","author":"U Schmidt-Erfurth","year":"2000","unstructured":"Schmidt-Erfurth U, Hasan T (2000) Mechanism of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol 45:195\u2013214","journal-title":"Surv Ophthalmol"},{"key":"1651_CR20","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00347-008-1691-5","volume":"105","author":"MF Niegel","year":"2008","unstructured":"Niegel MF, Schrage NF, Christmann S, Degenring RF (2008) Intravitreal bevacizumab for chronic central serous chorioretinopathy. Ophthalmologe 105:943\u2013945","journal-title":"Ophthalmologe"},{"key":"1651_CR21","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00417-008-0856-x","volume":"246","author":"ME Torres-Soriano","year":"2008","unstructured":"Torres-Soriano ME, Garc\u00eda-Aguirre G, Kon-Jara V, Ustariz-Gonz\u00e1les O, Abraham-Mar\u00edn M, Ober MD, Quiroz-Mercado H (2008) A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports). Graefes Arch Clin Exp Ophthalmol 246:1235\u20131239","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1651_CR22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/112067210901900415","volume":"19","author":"KB Schaal","year":"2009","unstructured":"Schaal KB, Hoeh AE, Scheuerle A, Schuett F, Dithmar S (2009) Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy. Eur J Ophthalmol 19:613\u2013617","journal-title":"Eur J Ophthalmol"},{"key":"1651_CR23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/IAE.0b013e3181bcf0b4","volume":"30","author":"SJ Lim","year":"2010","unstructured":"Lim SJ, Roh MI, Kwon OW (2010) Intravitreal bevacizumab injection for central serous chorioretinopathy. Retina 30:100\u2013106","journal-title":"Retina"},{"key":"1651_CR24","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00417-007-0568-7","volume":"245","author":"MS Spitzer","year":"2007","unstructured":"Spitzer MS, Yoeruek E, Sierra A, Wallenfels-Thilo B, Schraermeyer U, Spitzer B et al (2007) Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (lucentis) on different ocular cells. Graefes Arch Clin Exp Ophthalmol 245:1837\u20131842","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1651_CR25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/IAE.0b013e3181bcedbe","volume":"30","author":"Y Hatta","year":"2010","unstructured":"Hatta Y, Ishikawa K, Nishihara H, Ozawa S, Ito Y, Terasaki H (2010) Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography. Retina 30:495\u2013502","journal-title":"Retina"},{"key":"1651_CR26","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","volume":"115","author":"WM Chan","year":"2008","unstructured":"Chan WM, Lai TY, Lai RY, Liu DT, Lam DS (2008) Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 115:1756\u20131765","journal-title":"Ophthalmology"},{"key":"1651_CR27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/bjo.2006.093328","volume":"90","author":"JM Stewart","year":"2006","unstructured":"Stewart JM (2006) Half dose verteporfin PDT for central serous chorioretinopathy. Br J Ophthalmol 90:805\u2013806","journal-title":"Br J Ophthalmol"},{"key":"1651_CR28","doi-asserted-by":"crossref","first-page":"307.e2","DOI":"10.1016\/j.ajo.2009.08.026","volume":"149","author":"M Reibaldi","year":"2010","unstructured":"Reibaldi M, Cardascia N, Longo A, Furino C, Avitabile T, Faro S, Sanfilippo M, Russo A, Uva MG, Munno F, Cannemi V, Zagari M, Boscia F (2010) Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol 149:307.e2\u2013315.e2","journal-title":"Am J Ophthalmol"},{"key":"1651_CR29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/IAE.0b013e3181e378f2","volume":"31","author":"JY Shin","year":"2011","unstructured":"Shin JY, Woo SJ, Yu HG, Park KH (2011) Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy. Retina 31:119\u2013126","journal-title":"Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1651-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-011-1651-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1651-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T10:10:56Z","timestamp":1560075056000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-011-1651-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,30]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["1651"],"URL":"https:\/\/doi.org\/10.1007\/s00417-011-1651-7","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,30]]}}}